恩华药业：2025年半年度报告摘要

Core Viewpoint - Enhua Pharmaceutical announced a net profit attributable to shareholders of 700,494,742.07 yuan for the first half of 2025, representing a year-on-year increase of 11.38% [2] Financial Performance - The net profit for the first half of 2025 is reported at 700,494,742.07 yuan [2] - This figure indicates a growth of 11.38% compared to the same period last year [2]